Grufity logo
Grufity logo
PRPO

PRPO - Precipio Inc Stock Price, Fair Value and News

$22.27-0.17 (-0.76%)
Market Closed as of 16 Jun 2026, 04:00 pm ET

68/100

PRPO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

68/100

PRPO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

PRPO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PRPO Price Action

Last 7 days

-2.4%

Last 30 days

-13.8%

Last 90 days

-23.5%

Trailing 12 Months

106.8%

PRPO RSI Chart

PRPO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PRPO Valuation

Market Cap

40.0M

Price/Earnings (Trailing)

-43.41

Price/Sales (Trailing)

1.54

EV/EBITDA

99.75

Price/Free Cashflow

67.73

PRPO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

PRPO Fundamentals

PRPO Revenue

Revenue (TTM)

26.0M

Rev. Growth (Yr)

36.15%

Rev. Growth (Qtr)

-1.3%

PRPO Earnings

Earnings (TTM)

-922.0K

Earnings Growth (Yr)

-63.24%

Earnings Growth (Qtr)

-374.33%

PRPO Profitability

EBT Margin

-3.54%

Return on Equity

-6.51%

Return on Assets

-4.43%

Free Cashflow Yield

1.48%

PRPO Investor Care

Shares Dilution (1Y)

18.57%

Diluted EPS (TTM)

-0.46

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
202626.0M---
202520.0M21.2M22.8M24.3M
202416.0M16.8M17.5M18.5M
202310.1M11.3M13.6M15.4M
20229.1M9.3M9.5M9.8M
20216.7M7.3M7.4M8.7M
20204.7M5.1M6.1M6.1M
20193.6M3.8M4.0M4.1M
20182.5M3.2M3.7M3.4M
20172.0M1.7M1.5M2.0M
20161.4M1.6M1.7M1.9M
201519.3M13.0M9.2M1.9M
201426.4M25.9M23.3M24.8M
201331.6M29.9M28.6M27.5M
201231.7M33.1M32.8M31.5M
2011-24.7M28.5M32.0M
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Precipio Inc

PRPO
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.
 CEO
 WEBSITEprecipiodx.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES53

Precipio Inc Frequently Asked Questions

PRPO is the stock ticker symbol of Precipio Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Mon Jun 15 2026, market cap of Precipio Inc is 40.03 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Mon Jun 15 2026, PRPO's PE ratio (Price to Earnings) is -43.41 and Price to Sales (PS) ratio is 1.54. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PRPO PE ratio will change depending on the future growth rate expectations of investors.